[go: up one dir, main page]

DK1861130T3 - Anordning og fremgangsmåde til behandling af dermatomycosis og navnlig onychomycosis - Google Patents

Anordning og fremgangsmåde til behandling af dermatomycosis og navnlig onychomycosis

Info

Publication number
DK1861130T3
DK1861130T3 DK06708228T DK06708228T DK1861130T3 DK 1861130 T3 DK1861130 T3 DK 1861130T3 DK 06708228 T DK06708228 T DK 06708228T DK 06708228 T DK06708228 T DK 06708228T DK 1861130 T3 DK1861130 T3 DK 1861130T3
Authority
DK
Denmark
Prior art keywords
nitric oxide
eluting polymer
treatment
dermatomycosis
onychomycosis
Prior art date
Application number
DK06708228T
Other languages
English (en)
Inventor
Tor Peters
Original Assignee
Nolabs Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05002936A external-priority patent/EP1690554A1/en
Priority claimed from EP05018269A external-priority patent/EP1757278A1/en
Application filed by Nolabs Ab filed Critical Nolabs Ab
Application granted granted Critical
Publication of DK1861130T3 publication Critical patent/DK1861130T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/10—Bandages or dressings; Absorbent pads specially adapted for fingers, hands or arms; Finger-stalls; Nail-protectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/10—Bandages or dressings; Absorbent pads specially adapted for fingers, hands or arms; Finger-stalls; Nail-protectors
    • A61F13/104—Bandages or dressings; Absorbent pads specially adapted for fingers, hands or arms; Finger-stalls; Nail-protectors for the hands or fingers
    • A61F13/105—Bandages or dressings; Absorbent pads specially adapted for fingers, hands or arms; Finger-stalls; Nail-protectors for the hands or fingers for the fingers; Finger-stalls; Nail-protectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B21/00—Nitrogen; Compounds thereof
    • C01B21/20—Nitrogen oxides; Oxyacids of nitrogen; Salts thereof
    • C01B21/24—Nitric oxide (NO)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
    • A61F13/064—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
    • A61F13/064—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet
    • A61F13/068—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet for the toes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06708228T 2005-02-11 2006-02-13 Anordning og fremgangsmåde til behandling af dermatomycosis og navnlig onychomycosis DK1861130T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05002936A EP1690554A1 (en) 2005-02-11 2005-02-11 Device for treatment of infections, including dermatophytosis and onychomycosis
US65275905P 2005-02-14 2005-02-14
EP05018269A EP1757278A1 (en) 2005-08-23 2005-08-23 Device, system, and method comprising microencapsulated liquid for release of nitric oxide from a polymer
US71100605P 2005-08-24 2005-08-24
PCT/EP2006/050889 WO2006084910A2 (en) 2005-02-11 2006-02-13 Device and method for treatment of dermatomycosis, and in particular onychomycosis

Publications (1)

Publication Number Publication Date
DK1861130T3 true DK1861130T3 (da) 2009-01-26

Family

ID=39189566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06708228T DK1861130T3 (da) 2005-02-11 2006-02-13 Anordning og fremgangsmåde til behandling af dermatomycosis og navnlig onychomycosis

Country Status (14)

Country Link
US (1) US20080071206A1 (da)
EP (1) EP1861130B1 (da)
JP (1) JP2008529626A (da)
KR (1) KR20070104408A (da)
AT (1) ATE407708T1 (da)
BR (1) BRPI0606829A2 (da)
CA (1) CA2594408A1 (da)
DE (1) DE602006002726D1 (da)
DK (1) DK1861130T3 (da)
ES (1) ES2314882T3 (da)
MX (1) MX2007009691A (da)
PL (1) PL1861130T3 (da)
PT (1) PT1861130E (da)
WO (1) WO2006084910A2 (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1718316A4 (en) 2004-02-09 2009-05-13 Amulet Pharmaceuticals Inc STAIN OXIDE RELEASING POLYMERS
DE602006006432D1 (de) 2005-03-24 2009-06-04 Nolabs Ab Kosmetische behandlung mit stickoxid, vorrichtung zur durchführung dieser behandlung und herstellungsverfahren dafür
WO2006128121A2 (en) 2005-05-27 2006-11-30 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
SE529056C2 (sv) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasmaalstrande anordning, plasmakirurgisk anordning och användning av en plasmakirurgisk anordning
SE529058C2 (sv) * 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasmaalstrande anordning, plasmakirurgisk anordning, användning av en plasmakirurgisk anordning och förfarande för att bilda ett plasma
SE529053C2 (sv) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasmaalstrande anordning, plasmakirurgisk anordning och användning av en plasmakirurgisk anordning
US7928338B2 (en) * 2007-02-02 2011-04-19 Plasma Surgical Investments Ltd. Plasma spraying device and method
CA2687640A1 (en) * 2007-03-27 2008-10-02 Nolabs Ab Topical dermal delivery device for nitric oxide delivery
US8735766B2 (en) * 2007-08-06 2014-05-27 Plasma Surgical Investments Limited Cathode assembly and method for pulsed plasma generation
US7589473B2 (en) * 2007-08-06 2009-09-15 Plasma Surgical Investments, Ltd. Pulsed plasma device and method for generating pulsed plasma
AU2008301195A1 (en) 2007-09-21 2009-03-26 Enox Biopharma, Inc. Antimicrobial gas-releasing ear drainage tubes
WO2009155690A1 (en) * 2008-06-24 2009-12-30 Micropharma Limited Nitric oxide compositions and devices and methods for cosmesis
GB0901456D0 (en) * 2009-01-29 2009-03-11 Insense Ltd Treatment of psoriasis
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
CN102711729B (zh) 2009-08-21 2015-04-01 诺万公司 局部用凝胶
US8613742B2 (en) * 2010-01-29 2013-12-24 Plasma Surgical Investments Limited Methods of sealing vessels using plasma
WO2011127181A2 (en) * 2010-04-06 2011-10-13 Syracuse University System and method for the release of nitric oxide using nanoscale media
WO2011140126A2 (en) * 2010-05-03 2011-11-10 Spenco Medical Corporation Nail discoloration and fungus treatment
EP2575829A4 (en) * 2010-06-07 2014-04-30 Topical Pharma Ab KIT FOR THE TREATMENT OF ONYCHOMYCOSIS BY NITRIC OXIDE
US9089319B2 (en) 2010-07-22 2015-07-28 Plasma Surgical Investments Limited Volumetrically oscillating plasma flows
US20120023634A1 (en) * 2010-08-02 2012-02-02 Jeffrey Lynn Kiser Male pant protector
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
EP2681286B1 (en) 2011-02-28 2018-08-15 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
JP6277124B2 (ja) 2011-07-05 2018-02-07 ノヴァン，インコーポレイテッド 局所用組成物
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
US11077194B2 (en) 2012-03-14 2021-08-03 Novan, Inc. Nitric oxide releasing pharmaceutical compositions
US9480829B2 (en) 2013-01-17 2016-11-01 Tamicare Ltd. All direction stretchable dressing article associated with curable materials
US10010445B2 (en) 2013-01-23 2018-07-03 Jonathan Isserow Treatment device using nanotechnology
US9636521B2 (en) 2013-07-12 2017-05-02 Jonathan Isserow Heat and light treatment device using nanotechnology
US10583037B2 (en) 2013-01-23 2020-03-10 Transqtronics, Llc. Heating device using exothermic chemical reaction
US9675817B2 (en) 2013-01-23 2017-06-13 Jonathan Isserow Heating device using exothermic chemical reaction
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US10206947B2 (en) 2013-08-08 2019-02-19 Novan, Inc. Topical compositions and methods of using the same
JP6513667B2 (ja) 2013-08-08 2019-05-15 ノヴァン，インコーポレイテッド 局所用組成物およびそれを使用する方法
EP3166593B1 (en) 2014-07-11 2020-05-20 Novan, Inc. Topical antiviral compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
WO2016010988A1 (en) 2014-07-14 2016-01-21 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
US10849864B2 (en) 2015-07-28 2020-12-01 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
JP7090549B2 (ja) 2016-03-02 2022-06-24 ノヴァン，インコーポレイテッド 炎症のための治療用組成物およびその治療方法
KR102426006B1 (ko) 2016-04-13 2022-07-29 노반, 인크. 감염 치료용 조성물, 시스템, 키트, 및 방법
US10568769B2 (en) * 2016-05-27 2020-02-25 Evadne I. Hutchful Fabric sleeves covering toe and finger blemishes and treating said blemishes
US11285171B2 (en) 2018-03-01 2022-03-29 Novan, Inc. Nitric oxide releasing suppositories and methods of use thereof
CN110052995B (zh) * 2019-05-30 2024-03-29 山东交通学院 一种辅助拇指指甲及活塞环拆装工具
EP4205515A2 (en) 2020-08-28 2023-07-05 Plasma Surgical Investments Limited Systems, methods, and devices for generating predominantly radially expanded plasma flow
FR3140537A1 (fr) * 2022-10-07 2024-04-12 HealthRock Capital SA Dispositif médical apte à couvrir l’ongle d’un orteil ou d’un doigt

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814666A (en) * 1992-04-13 1998-09-29 The United States As Represented By The Department Of Health And Human Services Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
WO1995022335A1 (en) * 1994-02-21 1995-08-24 Aberdeen University Acidified nitrite as an antimicrobial agent
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US5519020A (en) * 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
EP0805662B1 (en) * 1995-01-26 2000-11-02 Advanced Medical Solutions Limited Wound dressing
US5770645A (en) * 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US5958427A (en) * 1996-11-08 1999-09-28 Salzman; Andrew L. Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
US20040043068A1 (en) * 1998-09-29 2004-03-04 Eugene Tedeschi Uses for medical devices having a lubricious, nitric oxide-releasing coating
US6382526B1 (en) * 1998-10-01 2002-05-07 The University Of Akron Process and apparatus for the production of nanofibers
US6737447B1 (en) * 1999-10-08 2004-05-18 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
US6627301B2 (en) * 2000-03-28 2003-09-30 Showa Denko Kabushiki Kaisha Magnetic recording medium
HUP0002628A2 (en) * 2000-07-14 2002-06-29 Keri Pharma Kft Pharmaceutical combinations for treating diabetes
US6780849B2 (en) * 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US6706274B2 (en) * 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
US6520425B1 (en) * 2001-08-21 2003-02-18 The University Of Akron Process and apparatus for the production of nanofibers
US6703046B2 (en) * 2001-10-04 2004-03-09 Medtronic Ave Inc. Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
US6695992B2 (en) * 2002-01-22 2004-02-24 The University Of Akron Process and apparatus for the production of nanofibers
AU2003218041A1 (en) * 2002-03-07 2003-09-22 Board Of Regents, The University Of Texas System Conformable bi-laminate compression bolster and method for using same
AU2003281815A1 (en) * 2002-08-02 2004-02-23 The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Hu Cross-linked nitric oxide-releasing polyamine coated substrates, compositions comprising same and method of making same
US7972137B2 (en) * 2003-06-30 2011-07-05 Rosen Gerald M Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
ES2645566T3 (es) * 2003-07-03 2017-12-05 The University Court Of The University Of St Andrews Zeolitas para el suministro de óxido nítrico
EP1827332A4 (en) * 2004-11-29 2010-03-17 Univ Akron TOPICAL STAINED OXIDE DONATING DEVICES AND METHOD FOR THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
BRPI0606829A2 (pt) 2009-07-21
EP1861130B1 (en) 2008-09-10
WO2006084910A3 (en) 2007-03-08
MX2007009691A (es) 2008-02-12
ATE407708T1 (de) 2008-09-15
ES2314882T3 (es) 2009-03-16
US20080071206A1 (en) 2008-03-20
JP2008529626A (ja) 2008-08-07
KR20070104408A (ko) 2007-10-25
WO2006084910A2 (en) 2006-08-17
PL1861130T3 (pl) 2009-02-27
CA2594408A1 (en) 2006-08-17
EP1861130A2 (en) 2007-12-05
PT1861130E (pt) 2008-12-02
DE602006002726D1 (de) 2008-10-23

Similar Documents

Publication Publication Date Title
DK1861130T3 (da) Anordning og fremgangsmåde til behandling af dermatomycosis og navnlig onychomycosis
WO2006084912A8 (en) Device method, and use for treatment of neuropathy involving nitric oxide
JO2858B1 (en) Pharmaceutical dosage images
WO2006084911A3 (en) Improved device for application of medicaments, manufacturing method therefor, and method of treatment
DK1871433T3 (da) Kosmetisk behandling med nitrogenoxid, anordning til udförelse af denne behandling samt fremstillingsproces dertil
TW200630093A (en) Dose forms
NZ624059A (en) Therapeutic applications of activation of human antigen-presenting cells through dectin-1
CL2008001125A1 (es) Compuestos derivados de pirimidinona condensada con heterociclos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, sindrome metabolico y obesidad.
SV2006002131A (es) Uso de un anticuerpo para el tratamiento de lupus
CL2008001126A1 (es) Compuestos derivados de pirimidinona condensada con heterociclos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, sindrome metabolico y obesidad.
ECSP066805A (es) Compuestos silinano como inhibidores de cisteína proteasa
UA101044C2 (ru) Композиция для местного применения для лечения актинического кератоза
MX2009012598A (es) Formas de dosis que comprenden vx-950 y su regimen de dosificacion.
ATE497392T1 (de) Therapie mit anti-cd4-antikörpern und bestrahlung
ATE540690T1 (de) Insulinkombinationen
AR045870A1 (es) Terapia de combinacion para la infeccion de virus de hepatitis c
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
SE0300971D0 (sv) Nitric oxide in treatment of inflammation
CL2020001358A1 (es) Cepa vacunal de brucella modificada para el tratamiento de brucelosis
WO2006084913A3 (en) Device for treatment of rectal disorders, and manufacturing process for the same, involving nitric oxide
WO2006084914A3 (en) Device for gastric treatment and manufacturing process for the same
AR052165A1 (es) Tratamiento de hepatitis c en la poblacion asiatica
ES2723778T3 (es) Terapia dirigida a células madre cancerosas y contra cáncer resistente a fármacos
AR053154A1 (es) Metodo de tratamiento y combinacion de roflumilast y un inhibidor de integrina
BR112022004941A2 (pt) Métodos para tratar doenças autoimunes com o uso de antagonistas de interleucina-17 (il-17)